CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore La Jolla Institute For Allergy And Immunology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment1
Aug 16, 2017Antagonistic Hlight-Specific Human Monoclonal Antibodies1

Top competitors of La Jolla Institute For Allergy And Immunology

Top competitors of La Jolla Institute For Allergy And Immunology based on patent oppositions.